OLENPHOGY Details Advanced Inositol Complex to Elevate the 40:1 Standard

BRANDON, Fla. - Rezul -- OLENPHOGY, a U.S.-based wellness brand specializing in precision supplementation, has officially detailed the scientific rationale behind its newly released Advanced Inositol Complex. While the industry standard has largely settled on the 40:1 ratio of Myo-Inositol to D-Chiro-Inositol (DCI), OLENPHOGY's latest formulation represents a significant biochemical upgrade by integrating targeted synergistic co-factors.

In recent years, the 40:1 inositol ratio has become widely recognized as the baseline for supporting insulin sensitivity, ovarian function, and hormonal balance. However, clinical observations indicate that providing the raw inositol isomers alone does not always guarantee optimal cellular utilization, especially in individuals with compromised metabolic pathways or methylation deficits.

More on Rezul News

• Host Reports $11,000 Property Loss Following Guest "Courtney Potts" Stay
• Class is in session: Black Beauty Block Party returns to Los Angeles for fourth annual festival
• Heavy Duty Journal Surpasses 1000 Technical Articles for Diesel Technicians and Fleet Managers
• Kolbus Introduces the Next Step in Casemaking Efficiency
• Global Real Estate Pro Launches International Real Estate Mobile App

To address this limitation, the research and development team at OLENPHOGY engineered a synergistic matrix. The Advanced Inositol Complex builds upon the foundational 40:1 ratio by incorporating L-5-Methyltetrahydrofolate (5-MTHF), the fully active, bioavailable form of folate.

This specific combination creates a powerful biological synergy: while the 40:1 inositol ratio restores cellular signaling mechanisms, the bioactive co-factors simultaneously support healthy methylation and enhance the overall metabolic response. This integrated approach ensures that the active ingredients are not just delivered to the bloodstream, but are efficiently utilized at the cellular level.

"The 40:1 ratio is no longer an innovation; it is simply a baseline requirement for any effective inositol supplement," said Dr. Marcus Lin, Director of Clinical Research at OLENPHOGY. "Our goal was to upgrade this standard. By integrating active synergistic co-factors directly into the formulation, we bypass common absorption bottlenecks and provide a comprehensive solution that supports total metabolic and endocrine health more efficiently than isolated inositol alone."

More on Rezul News

• Florida Law Advisers, P.A. Named Best Divorce Firm of 2026 by Expert Law Attorneys
• Lakeland Home Sale Prices Hold Steady as Inventory Rises and Buyers Gain Negotiating Room
• Sounds of LA County: 27 Parks.108 Concerts. One County
• Only One Flight Stands Between Los Angeles Youth Leaders and a Life-Saving Mission in South Africa
• CENTURY 21 Circle Appoints Sara Valko Director of Marketing & Brand Strategy

Consistent with the brand's stringent quality standards, the Advanced Inositol Complex utilizes strictly high-purity ingredients without unverified proprietary blends. The product is 100% vegan, non-GMO, third-party tested, and manufactured in a U.S.-based, cGMP-compliant facility—completely free of gluten, soy, dairy, and artificial fillers.

For technical specifications regarding the synergistic ingredients and to review the complete nutritional profile, please visit: https://olenphogy.com/products/myo-d-chiro-inositol-40-1

About OLENPHOGY: OLENPHOGY is a U.S.-based premium wellness brand dedicated to smarter, precision-driven supplementation. Built on the principles of science, purity, precision, and efficiency, the brand develops clinically inspired formulas manufactured in cGMP-compliant facilities and validated through multi-stage quality testing to support intentional, informed wellness living.

Contact
Attn: PR Manager Hebe Lee
Email: hello@olenphogy.com
Phone: +1-888-588-6536
Website: https://olenphogy.com